Ann Marie Leonard Zabel, Curry College, United States
Current trends indicate a rise in aggressive and violent behaviors among conduct disordered adolescents, often compounded by co-occurring substance use disorders. Understanding the neurochemical pathways involved in these conduct disorders is crucial for developing effective inte [....] » Read More
Title : Step one therapy
Ashton Christopher, Center for Recovery, Canada
In 1939, Alcoholics Anonymous (AA) World Services Inc. published its text which, remarkably, is still in broad use today and shows no signs of losing popularity. Within the profession of caring for people suffering from addictions of all types in residential and ambulatory c [....] » Read More
Title : Neurobiology of addiction
Meera Vaswani, All India Institute of Medical Sciences (AIIMS), India
Addiction was historically viewed as a disease of “weak personality” and was not systematically addressed by the scientific and medical communities until the latter half of the 20th century. They are now commonly accepted as diseases of the brain caused by the i [....] » Read More
Title : The PAWsitive model keeping families together and helping people and pets heal from the wounds of addiction, trauma, and abuse.
Serena Saunders, SPCA International, United States
Addiction and trauma tear lives apart—often forcing individuals to choose between getting help and keeping their beloved pets. The PAWsitive Recovery Program is a trauma-informed, pet-centered support model designed to bridge that gap. Our approach offers crisis foster care [....] » Read More
Title : Crisis care 2.0: Transforming substance use systems into recovery gateways
Charles Thomas Browning, Behavorial Health Link, United States
Around the world, crisis care systems are evolving to meet the rising needs of individuals with mental health and substance use challenges. Yet, substance use disorder (SUD) treatment too often remains siloed in crisis services, limiting impact and leaving opportunities for engag [....] » Read More
Title : Changing patterns of adolescent addictive behaviors in the US and Europe: Success or substitution?
Jana Furstova, Palacký University Olomouc, Czech Republic
Objectives: This study examines changes in the prevalence of adolescent addictive behaviors between 2002 and 2022 across 39 European countries and the United States. Methods: Data were analyzed from 15-year-old adolescents participating in the Youth Risk Behavior Surveillance [....] » Read More
Title : Connection is the opposite of addiction: Using digital tools to drive connection in clinical settings
Elana Deuble, Community Medical Services, United States
In recovery, connection isn’t a luxury-it’s a lifeline. In a world where digital access is high but emotional connection is low, clinical programs have an urgent opportunity: to use technology not to replace, but to enhance human connection. This presentation highli [....] » Read More
Title : Connection is the opposite of addiction: Using digital tools to drive connection in clinical settings
Sara Lorenzen, Bright Therapeutics, United States
In recovery, connection isn’t a luxury-it’s a lifeline. In a world where digital access is high but emotional connection is low, clinical programs have an urgent opportunity: to use technology not to replace, but to enhance human connection. This presentation highligh [....] » Read More
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States
Background: Extended-release intramuscular naltrexone (XR-NTX; Vivitrol®) reduces relapse risk in opioid use disorder (OUD), but real-world adherence is only about 10 percent at 6 months. One reason for poor adherence is the decline in plasma NTX levels to below therapeutic l [....] » Read More
Title : The hidden traps: Understanding gambling and gaming addiction
Matthew Langford, Kindbridge Research Institute, United States
Gambling and gaming addiction are rapidly emerging public health concerns that intersect psychology, neuroscience, and social behavior. This talk will explore the underlying mechanisms of these addictions, including the role of reward circuitry, variable reinforcement schedules, [....] » Read More
Title : Physiologically based pharmacokinetic model to predict lofexidine level during lactation
Tao Zhang, SUNY-Binghamton University, United States
Lofexidine (LUCEMYRA®) is currently the only FDA-approved treatment for opioid withdrawal that is both non-opioid and non-addictive, making it especially important for use in pregnant and postpartum women amid the opioid crisis. However, limited information exists regarding i [....] » Read More